However, another key risk is that the 2025 expansion cohort update in ovarian cancer could see a similar "sell the news" reaction to this year's ESMO data. One more concern is that I'm not sure ...

Called "Project 2025," the blueprint was invoked by President Biden, Harris and other Democrats throughout the campaign as they sought to sound the alarm about what could be in store if Trump won ...

The Social Security Administration has announced a 2.5% cost-of-living adjustment (COLA) to benefit checks starting in 2025. That's down from the 3.2% increase in 2024 and the smallest COLA ...

Now, new data from the POD1UM-303 study reported at ESMO suggests the company could ... with a phase 3 programme that is due to start in 2025. Eisai has retreated from the optimistic view of ...

The IRS has announced the 2025 contribution limits for 401(k) and IRAs. Employees can defer $23,500 into workplace plans, a modest increase from $23,000 in 2024. The change applies to 401(k ...

One of the key figures behind the Project 2025 policy manifesto extended enthusiastic congratulations to former President Donald Trump following his victory in the 2024 presidential election.

Merus’ zenocutuzumab is nearing FDA approval, and petosemtamab shows promise. Learn why MRUS stock could rise as the company ...

Economists expect more interest rate cuts in 2025 and 2026. The federal funds rate, determined by the U.S. Federal Reserve, is a crucial interest rate for Americans. It indirectly influences ...

In this article we have chronicled every game coming in 2025 and beyond, split into each month they are being released. You can also find a huge collection of games that have been confirmed to ...

Global Phase 1 study of CLN-978 in systemic lupus erythematosus (SLE) cleared to initiate in U.S. and Australia; initial clinical data expected ...

Weekly Commentary (Updated Nov. 7, 2024): More to come. Read: You can see all Academy Award predictions in all 23 categories on one page on the Variety Awards Circuit: Oscars. The latest updates ...

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today reported financial results for the third quarter ...